- Report
- October 2023
- 172 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- July 2022
- 100 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- January 2021
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- November 2020
Europe
From €8682EUR$8,995USD£7,447GBP
- Report
- August 2018
- 115 Pages
Global
From €4536EUR$4,700USD£3,891GBP
- Report
- December 2019
- 290 Pages
Global
From €3861EUR$4,000USD£3,312GBP
- Report
- October 2020
United States
From €7717EUR$7,995USD£6,619GBP
- Report
- May 2023
- 117 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- May 2023
- 81 Pages
Global
From €3500EUR$3,884USD£3,107GBP
The Patent Foramen Ovale (PFO) Device market is a subset of the Cardiovascular Devices market. It is composed of medical devices used to close a hole in the heart, known as a patent foramen ovale (PFO). This hole is a natural opening between the two upper chambers of the heart, and it is present in about 25% of the population. PFO closure devices are used to reduce the risk of stroke and other neurological events. These devices are typically implanted during a minimally invasive procedure, and they are designed to remain in place for the lifetime of the patient.
The PFO Device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Abbott, Boston Scientific, W.L. Gore & Associates, and Occlutech. Show Less Read more
